LAMARK BIOTECH PVT LTD. is developing innovative molecular medicines to support sustainable and affordable healthcare systems globally. At Lamark, we believe that accessibility and affordability of medicines are as crucial as it ́s discovery.
#MolecularMedicine, i.e. #therapeuticProteins, #geneTherapies and #cellTherapies, have progressed exponentially in the last two decades. However, being overly priced, it is not expected that the current molecular medicines could be affordable to 99 per cent of the patients. Our mission is to make molecular medicine accessible to all. We envision to redesign existing medicines and develop innovative scientific solutions to promote sustainable business strategies and pricing models.
Company Details
- Employees
- 10
- Founded
- -
- Address
- Bengaluru-Mangaluru Hwy, Phase -1,peenya,india
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- lamarkbiotech.com
- Keywords
- R&D, diabetes, aging, cell therapy, gene therapy, protein engineering, genetic engineering, therapeutic proteins, immunotherapy, 3D printing.
- HQ
- Bengaluru, Karnataka
Lamark Biotech Questions
Lamark Biotech's website is lamarkbiotech.com
Lamark Biotech's LinkedIn profile is https://in.linkedin.com/company/lamarkbiotech
Lamark Biotech has
10 employees.
View email and phone details for 10
employees at Lamark Biotech.
Lamark Biotech's industry is
Biotechnology Research
Lamark Biotech's top competitors are
Eeki,
Zango,
Serigen Mediproducts (Official Account),
Cygenica Ltd.,
Lentistem Biotech S.l.,
Vircell S.l.,
Astrophel Aerospace,
Venture Center (Official Account),
Urjanovac Pvt Ltd,
Loopworm.
Lamark Biotech's categories are Biotechnology Research
Lamark Biotech's founding year is 2018
